BE735439A - - Google Patents

Info

Publication number
BE735439A
BE735439A BE735439DA BE735439A BE 735439 A BE735439 A BE 735439A BE 735439D A BE735439D A BE 735439DA BE 735439 A BE735439 A BE 735439A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE735439A publication Critical patent/BE735439A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
    • G02B27/02—Viewing or reading apparatus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE735439D 1968-07-01 1969-06-30 BE735439A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74180768A 1968-07-01 1968-07-01
US78725468A 1968-12-26 1968-12-26
US81943569A 1969-04-25 1969-04-25

Publications (1)

Publication Number Publication Date
BE735439A true BE735439A (cg-RX-API-DMAC10.html) 1969-12-30

Family

ID=27419280

Family Applications (1)

Application Number Title Priority Date Filing Date
BE735439D BE735439A (cg-RX-API-DMAC10.html) 1968-07-01 1969-06-30

Country Status (7)

Country Link
BE (1) BE735439A (cg-RX-API-DMAC10.html)
CH (1) CH515911A (cg-RX-API-DMAC10.html)
DE (1) DE1932396A1 (cg-RX-API-DMAC10.html)
ES (6) ES368949A1 (cg-RX-API-DMAC10.html)
FR (1) FR2012062A1 (cg-RX-API-DMAC10.html)
GB (1) GB1256593A (cg-RX-API-DMAC10.html)
NL (1) NL6909864A (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759671A (fr) * 1969-12-01 1971-06-01 Sandoz Sa Derives de la quinazolinone, leur preparation et medicaments contenant ces derives
DK129348B (da) * 1970-07-13 1974-09-30 Sumitomo Chemical Co Analogifremgangsmåde til fremstilling af 1-substituerede 3,4-dihydro-2(1H)-quinazolinonderivater.
DE2162327C3 (de) * 1970-12-23 1975-09-18 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
WO1993004047A1 (en) * 1991-08-16 1993-03-04 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
CA2124306C (en) * 1993-05-26 2004-04-06 Masami Muraoka Quinazolinone derivatives
WO2015120059A1 (en) * 2014-02-04 2015-08-13 Yates Charles Ryan Inhibitors of paxillin function and related compositions and methods

Also Published As

Publication number Publication date
ES368949A1 (es) 1971-07-16
NL6909864A (cg-RX-API-DMAC10.html) 1970-01-05
ES388760A1 (es) 1974-03-01
CH515911A (de) 1971-11-30
DE1932396A1 (de) 1970-01-08
ES388762A1 (es) 1974-03-01
FR2012062A1 (cg-RX-API-DMAC10.html) 1970-03-13
GB1256593A (cg-RX-API-DMAC10.html) 1971-12-08
ES388761A1 (es) 1974-03-01
ES388758A1 (es) 1974-03-01
ES388759A1 (es) 1974-03-01

Similar Documents

Publication Publication Date Title
AU1946070A (cg-RX-API-DMAC10.html)
AU5506869A (cg-RX-API-DMAC10.html)
AU2374870A (cg-RX-API-DMAC10.html)
AU5184069A (cg-RX-API-DMAC10.html)
AU6168869A (cg-RX-API-DMAC10.html)
FR2027023B1 (cg-RX-API-DMAC10.html)
AU6171569A (cg-RX-API-DMAC10.html)
AU429879B2 (cg-RX-API-DMAC10.html)
AU2581067A (cg-RX-API-DMAC10.html)
AU4811568A (cg-RX-API-DMAC10.html)
AU421558B1 (cg-RX-API-DMAC10.html)
AR203075Q (cg-RX-API-DMAC10.html)
AU3224368A (cg-RX-API-DMAC10.html)
AU4744468A (cg-RX-API-DMAC10.html)
AU2580267A (cg-RX-API-DMAC10.html)
BE728157A (cg-RX-API-DMAC10.html)
BE642636A (cg-RX-API-DMAC10.html)
BE581157A (cg-RX-API-DMAC10.html)
BE728095A (cg-RX-API-DMAC10.html)
BE709095A (cg-RX-API-DMAC10.html)
BE726538A (cg-RX-API-DMAC10.html)
BE727610A (cg-RX-API-DMAC10.html)
BE727168A (cg-RX-API-DMAC10.html)
BE722486A (cg-RX-API-DMAC10.html)
AU4464266A (cg-RX-API-DMAC10.html)